U.S. health officials evaluating Moderna bird flu vaccine, Bloomberg reports

U.S. health officials are reviewing the $590M deal for bird flu shots that the Biden administration awarded to Moderna (MRNA) in January, writes Madison Muller, Riley Griffin, and Ike Swetlitz for Bloomberg. This comes amid ” a record-breaking bird flu outbreak that’s affected dozens of cattle herds along with poultry flocks,” in the U.S., added the Bloomberg story. “While it is crucial that the US Department and Health and Human Services support pandemic preparedness, four years of the Biden administration’s failed oversight have made it necessary to review agreements for vaccine production,” said a spokesperson for HHS, according to the story…